MedMira announces the appointment of Dr. Sam Ratnam as Director of Scientific & Regulatory Affairs
The management and board is delighted to have Dr. Ratnam joining our growing team and support MedMira’s various regulatory applications. Dr. Ratnam brings over 40 years of experience in public health, regulatory affairs and has been the principal in a number of important regulations set forward by the health authorities such as the guidelines on Syphilis, Hepatitis C or HPV. His invaluable expertise and intrinsic knowledge of the regulatory and clinical trial framework in Canada and the United States, will provide the Company even further momentum to push forward in its current and future applications.
Dr. Sam Ratnam, MSc (Medical Microbiology; Madras), PhD (Medical Microbiology; Delhi), MPH (Johns Hopkins), FCCM (Fellow of Canadian College of Microbiologists), is Clinical Professor at Memorial University, St. John's, and Adjunct Professor, McGill University, Montreal, Canada. He was Director of Public Health Laboratory, Government of Newfoundland, St. John's, and served as Advisor to the National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, and Interim Advisor to the Public Health Laboratory, St. John's. He has served as chair or member of many Canadian federal and provincial advisory committees and working groups and as temporary advisor to the WHO. His research interests are clinical and public health microbiology with focus on STI diagnostics (200 scientific articles and abstracts).
“We are honoroud and proud to have such an esteemed expert to join us and we know he will be a great addition to our team. It is a personal privilege to work again alongside a long term supporter of our RVF Technology and its various applications.” said Hermes Chan, CEO of MedMira Inc. “I truly believe that his experience and leadership will bring the final push in Canada and the United States."